Occudo Quantitative Strategies LP Fibrogen Inc Transaction History

Occudo Quantitative Strategies LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$0.73 - $2.73 $23,185 - $86,707	-31,761 Reduced 44.85%	39,054 $91,000
Q2 2023 Aug 14, 2023	BUY	$2.49 - $20.59 $95,030 - $785,817	38,165 Added 116.89%	70,815 $191,000
Q1 2023 May 15, 2023	BUY	$15.95 - $25.18 $520,767 - $822,127	32,650 New	32,650 $609,000
Q3 2022 Nov 14, 2022	BUY	$11.4 - $14.6 $790,555 - $1.01 Million	69,347 New	69,347 $902,000
Q4 2021 Feb 14, 2022	SELL	$9.93 - $15.39 $320,729 - $497,081	-32,299 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$10.18 - $26.64 $328,803 - $860,445	32,299 New	32,299 $330,000

47.1M

387K

672K

Ticker FGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,741,200
Market Cap $32.8M
Description
FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...

Get notified when there are updates to the investment portfolio of Occudo Quantitative Strategies LP, based on Form 13F filings with the SEC.

Stay updated on Occudo Quantitative Strategies LP with notifications on news.